Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene.

We report successful electro-gene therapy (EGT) by using plasmid DNA for tumor-bearing mice. Subcutaneously inoculated CT26 tumor was subjected to EGT, which consists of intratumoral injection of a naked plasmid encoding a marker gene or a therapeutic gene, followed by in vivo electroporation (EP). When this treatment modality is carried out with the plasmid DNA for the green fluorescent protein gene, followed by in vivo EP with the optimized pulse parameters, numerous intensely bright green fluorescent signals appeared within the tumor. EGT, by using the "A" fragment of the diphtheria toxin gene significantly inhibited the growth of tumors, by about 30%, on the flank of mice. With the herpes simplex virus thymidine kinase gene, followed by systemic injection of ganciclovir, EGT was far more effective in retarding tumor growth, varying between 50% and 90%, compared with the other controls. Based on these results, it appears that EGT can be used successfully for treating murine solid tumors.

[1]  W. Hamel,et al.  Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. , 1996, Cancer research.

[2]  K. Yasuda,et al.  Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds , 1999, Nature.

[3]  M J Jaroszeski,et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy , 1996, Cancer.

[4]  J Teissié,et al.  Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. , 1990, Biophysical journal.

[5]  S. Sukharev,et al.  In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. , 1991, Biochimica et biophysica acta.

[6]  U. Zimmermann,et al.  Electric field-mediated fusion and related electrical phenomena. , 1982, Biochimica et biophysica acta.

[7]  G. A. Hofmann,et al.  Electrochemotherapy--a novel method of cancer treatment. , 1994, Cancer treatment reviews.

[8]  G. A. Hofmann,et al.  Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model. , 1998, Anticancer research.

[9]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[10]  G. Fishman,et al.  Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. , 1996, Gene therapy.

[11]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo , 1998, Nature Biotechnology.

[12]  R. Mulligan,et al.  The basic science of gene therapy. , 1993, Science.

[13]  T. Nishi,et al.  Targeted gene transfer to corneal endothelium in vivo by electric pulse , 1998, Gene Therapy.

[14]  G. A. Hofmann,et al.  Effective Electroporation Therapy of Human Pancreatic Tumors Implanted in Nude Mice. , 1997, Drug delivery.

[15]  J. Teissié,et al.  Long-lived macropinocytosis takes place in electropermeabilized mammalian cells. , 1995, Biochemical and biophysical research communications.

[16]  R K Jain,et al.  Barriers to drug delivery in solid tumors. , 1994, Scientific American.

[17]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.

[18]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[20]  E Neumann,et al.  Control by pulse parameters of electric field-mediated gene transfer in mammalian cells. , 1994, Biophysical journal.

[21]  Toshiyuki Matsuzaki,et al.  Direct gene transfer into rat liver cells by in vivo electroporation , 1998, FEBS letters.

[22]  M. Jaroszeski,et al.  Electrically enhanced drug delivery for the treatment of soft tissue sarcoma , 1999, Cancer.

[23]  J. Kuratsu,et al.  Production and characterization of human glioma cell-derived monocyte chemotactic factor. , 1989, Journal of the National Cancer Institute.

[24]  A. Graessmann,et al.  Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Ogino,et al.  Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. , 1998, Science.

[26]  J. Kuratsu,et al.  Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes. , 1997, Human cell.

[27]  G. A. Hofmann,et al.  Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice. , 1998, Anticancer research.

[28]  L. Mir,et al.  Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.

[29]  F. Moolten.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. , 1986, Cancer research.

[30]  Ronald G. Crystal,et al.  Transfer of Genes to Humans: Early Lessons and Obstacles to Success , 1995, Science.

[31]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[32]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[33]  T. Yagi,et al.  Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Kuratsu,et al.  High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. , 1996, Cancer research.

[35]  M. Rols,et al.  In vivo electrically mediated protein and gene transfer in murine melanoma , 1998, Nature Biotechnology.

[36]  R. Palmiter,et al.  Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene , 1987, Cell.

[37]  M. Brattain,et al.  Establishment of mouse colonic carcinoma cell lines with different metastatic properties. , 1980, Cancer research.

[38]  F. Ledley.  Nonviral gene therapy: the promise of genes as pharmaceutical products. , 1995, Human gene therapy.

[39]  H. Potter,et al.  Electroporation in biology: methods, applications, and instrumentation. , 1988, Analytical biochemistry.

[40]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[41]  D. Klatzmann,et al.  Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.